Facing the current pandemic, and having public health and safety as number one priority, inovapotek adopted a contingency plan on the 2nd of March, which has been regularly updated according to the evolution of the situation, and to Governmental and Directorate-General of Health instructions and recommendations.
inovapotek is also assuring the continuity of work, and assistance to all clients. Nevertheless, due to the current situation, clinical studies may be temporarily or partially compromised.
As always you can reach us by phone, by e-mail, or by skype.
Take care, kind regards,
